Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Supernus Pharmaceuticals stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for SUPN.
You can purchase shares of Supernus Pharmaceuticals (NASDAQ:SUPN) through any online brokerage.
Other companies in Supernus Pharmaceuticals’s space includes: Verona Pharma (NASDAQ:VRNA), WAVE Life Sciences (NASDAQ:WVE), Tarsus Pharmaceuticals (NASDAQ:TARS), Phibro Animal Health (NASDAQ:PAHC) and ANI Pharmaceuticals (NASDAQ:ANIP).
Supernus Pharmaceuticals has a consensus price target of $36.00.
The stock price for Supernus Pharmaceuticals (NASDAQ: SUPN) is $31.26 last updated March 14, 2025 at 4:00 PM EDT.
There are no upcoming dividends for Supernus Pharmaceuticals.
Supernus Pharmaceuticals’s Q1 earnings are confirmed for Wednesday, May 7, 2025.
There is no upcoming split for Supernus Pharmaceuticals.
Supernus Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.